EQL Pharma Overview
- Founded
-
2006
- Status
-
Public
- Employees
-
14
- Stock Symbol
-
EQL
- Share Price
-
$2.57
- (As of Friday Closing)
EQL Pharma General Information
Description
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.
Contact Information
Primary Industry
Pharmaceuticals
Stock Exchange
SAT
Primary Office
- Traktorvagen 11
- 226 60 Lund
- Sweden
+46 046-12 00 00
EQL Pharma Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.57 | $2.53 | $2.36 - $5.43 | $73.5M | 29.1M | 5.83K | $0.14 |
EQL Pharma Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2022 31-Mar-2022 | FY 2021 31-Mar-2021 | FY 2020 31-Mar-2020 |
|---|---|---|---|---|
| EV | 102,046 | 114,776 | 116,604 | 38,715 |
| Revenue | 45,634 | 46,429 | 20,128 | 7,514 |
| EBITDA | 4,754 | 4,401 | 1,295 | 760 |
| Net Income | 3,967 | 3,575 | 1,165 | 282 |
| Total Assets | 24,041 | 25,666 | 23,262 | 12,358 |
| Total Debt | 9,591 | 8,211 | 9,964 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
EQL Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
EQL Pharma Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Axel Schörling | Chief Executive Officer | ||
| Martin Kristofferson | Chief Operating Officer | ||
| Christer Fåhraeus Ph.D | Chief Executive Officer & President |
EQL Pharma Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 0å00000 | Self | Board Member | 000 0000 |
| 00000 0000000 | EQL Pharma | Board Member | 000 0000 |
| 000 000000000 | EQL Pharma | Board Member | 000 0000 |
| 000 00000000 | EQL Pharma | Board Member | 000 0000 |
| 00000 0000 00.0 | Self | Board Member | 000 0000 |
EQL Pharma Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
